Skip to content

Drug interactions

Conivaptan + Desogestrel-ethinyl estradiol

Severity: Minor

Conivaptan and Desogestrel-ethinyl estradiol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Conivaptan is a CYP3A4 inhibitor and may increase ethinyl estradiol and progestin concentrations. Conivaptan is used only short term as an IV infusion, so the effect is typically limited.

What this interaction means in plain words

Conivaptan and Desogestrel-ethinyl estradiol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 by conivaptan decreases metabolism of ethinyl estradiol.

What to do

No routine change is needed for the short infusion; monitor for estrogenic adverse effects such as nausea or breast tenderness.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Conivaptan and Desogestrel-ethinyl estradiol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Conivaptan with Desogestrel-ethinyl estradiol?

MediHelp rates the interaction as minor. Conivaptan and Desogestrel-ethinyl estradiol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Conivaptan is a CYP3A4 inhibitor and may increase ethinyl estradiol and progestin concentrations. Conivaptan is used only short term as an IV infusion, so the effect is typically limited.

How serious is the interaction between Conivaptan and Desogestrel-ethinyl estradiol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed for the short infusion; monitor for estrogenic adverse effects such as nausea or breast tenderness.

What other medicines interact with Desogestrel-ethinyl estradiol?

MediHelp also lists interactions of Desogestrel-ethinyl estradiol with, for example, Fezolinetant, Aminocaproic acid, Amobarbital. The full list is on the Desogestrel-ethinyl estradiol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in